Atypia in breast pathology: what pathologists need to know.

[1]  Peter J. Schüffler,et al.  (Re) Defining the High-Power Field for Digital Pathology , 2020, Journal of pathology informatics.

[2]  Yukako Yagi,et al.  Color standardization and optimization in whole slide imaging , 2020, Clinical and diagnostic pathology.

[3]  N. Rajpoot,et al.  Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study , 2020, Histopathology.

[4]  J. Solomon,et al.  Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ , 2020, The American journal of surgical pathology.

[5]  Vahid Soleimani,et al.  Breast Cytology and Pathology in Pregnancy and Lactation. , 2020, Advances in experimental medicine and biology.

[6]  G. Cserni,et al.  Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It? , 2019, Pathology & Oncology Research.

[7]  Eliah R. Shamir,et al.  Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center , 2019, The American journal of surgical pathology.

[8]  Thomas J. Fuchs,et al.  Whole slide imaging equivalency and efficiency study: experience at a large academic center , 2019, Modern Pathology.

[9]  C. Quinn,et al.  Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast , 2018, Journal of Clinical Pathology.

[10]  C. Quinn,et al.  Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast , 2018, Journal of Clinical Pathology.

[11]  I. Ellis,et al.  Impact of breast cancer grade discordance on prediction of outcome , 2018, Histopathology.

[12]  P. V. van Diest,et al.  Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification , 2018, Modern Pathology.

[13]  Darren Treanor,et al.  Digital pathology for the primary diagnosis of breast histopathological specimens: an innovative validation and concordance study on digital pathology validation and training , 2018, Histopathology.

[14]  D. Treanor,et al.  Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology , 2018, Journal of Clinical Pathology.

[15]  Daisuke Komura,et al.  Machine Learning Methods for Histopathological Image Analysis , 2017, Computational and structural biotechnology journal.

[16]  Clive R. Taylor,et al.  Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology , 2017, The American journal of surgical pathology.

[17]  I. Ellis,et al.  Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme , 2017, Histopathology.

[18]  C. Kleer,et al.  Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls. , 2016, Archives of pathology & laboratory medicine.

[19]  Ian O Ellis,et al.  Review of the national external quality assessment (EQA) scheme for breast pathology in the UK , 2016, Journal of Clinical Pathology.

[20]  C. Cohen,et al.  Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. , 2016, Archives of pathology & laboratory medicine.

[21]  S. Masuda,et al.  Adenomyoepithelioma with carcinoma of the breast: A report of two cases and a review of the literature. , 2016, Pathology, research and practice.

[22]  I. Ellis,et al.  Phyllodes tumours of the breast: a consensus review , 2016, Histopathology.

[23]  Mike Hale,et al.  Quantification of histochemical stains using whole slide imaging: development of a method and demonstration of its usefulness in laboratory quality control , 2014, Journal of Clinical Pathology.

[24]  J. Jones,et al.  Diagnostically challenging cases: what are atypia and dysplasia? , 2013, The Urologic clinics of North America.

[25]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[26]  E. Rakha.  The low nuclear grade breast neoplasia family , 2012 .

[27]  M. Morrow,et al.  Is There a Low-Grade Precursor Pathway in Breast Cancer? , 2012, Annals of Surgical Oncology.

[28]  J. Reis-Filho,et al.  Breast cancer precursors revisited: molecular features and progression pathways , 2010, Histopathology.

[29]  Shu Ichihara,et al.  Breast cancer prognostic classification in the molecular era: the role of histological grade , 2010, Breast Cancer Research.

[30]  S. Pinder.  Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation , 2010, Modern Pathology.

[31]  Donald L Weaver,et al.  Protocol for the examination of specimens from patients with invasive carcinoma of the breast. , 2009, Archives of pathology & laboratory medicine.

[32]  H. Heneghan,et al.  A diagnostic dilemma in breast pathology – benign fibroadenoma with multinucleated stromal giant cells , 2008, Diagnostic pathology.

[33]  Ian O Ellis,et al.  Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. Fischer,et al.  Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.

[35]  J. Thiery,et al.  Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast , 2008, Clinical Cancer Research.

[36]  Charles M. Perou,et al.  Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution , 2008, Clinical Cancer Research.

[37]  E. Provenzano,et al.  Vascular proliferations of the breast , 2007, Histopathology.

[38]  I. Ellis,et al.  Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast , 2008, Breast Cancer Research and Treatment.

[39]  D. Dabbs,et al.  Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile , 2006, Modern Pathology.

[40]  Sunil Badve,et al.  Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast , 2006, Modern Pathology.

[41]  I. Ellis,et al.  Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?: A Morphological and Molecular Analysis , 2005, The American journal of surgical pathology.

[42]  G. Moore,et al.  Radiation-induced Histopathologic Changes of the Breast: The Effects of Time , 2004, The American journal of surgical pathology.

[43]  M Bracko,et al.  Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. , 2002, Journal of clinical pathology.

[44]  A. Bankfalvi,et al.  Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast , 2000, Histopathology.

[45]  Atif A Ahmed,et al.  Malignant adenomyoepithelioma of the breast with malignant proliferation of epithelial and myoepithelial elements: a case report and review of the literature. , 2000, Archives of pathology & laboratory medicine.

[46]  J. Palazzo,et al.  Hyperplastic Ductal and Lobular Lesions and Carcinomas In Situ of the Breast: Reproducibility of Current Diagnostic Criteria Among Community‐ and Academic‐Based Pathologists , 1998, The breast journal.

[47]  C. Gillett,et al.  The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. , 1994, British Journal of Cancer.

[48]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[49]  M. Merino,et al.  The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. , 1990, Human pathology.

[50]  R. Millis,et al.  Radiation and other pathological changes in breast tissue after conservation treatment for carcinoma. , 1990, Journal of clinical pathology.

[51]  P. Close,et al.  The effect of chemotherapy on the morphology of human breast carcinoma. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.